BridgeMD
New treatment option for Pain, Chronic
Official title VR and Cooled Genicular Nerve Radio Frequency Ablation for Chronic Knee Pain
ClinicalTrials.gov ID: NCT06336447
What this study is testing
- What it's testing
- This study will examine the impact of virtual reality used in conjunction with sedation compared to sedation alone in patients undergoing watervcooled genicular nerve ablations for chronic knee pain. The goals of the study is to determine the relative efficacy of virtual reality as a distraction modality when used as an adjuvant to procedural sedation compared to sedation alone for procedure related pain.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients undergoing genicular RFA will be eligible for inclusion in the study
- Patients with knee pain, baseline average of \> 4/10
- X-ray evidence of osteoarthritis of the knee
- Pain duration of \>6 weeks and no previous knee surgeries
- Patients will also only be included who have never undergone a RFA on the affected knee
You likely can't join if
- Individuals who do not have evidence of osteoarthritis on X-ray,
- Secondary gain expected to influence treatment outcomes
- Poorly controlled psychiatric condition that could affect outcome (e.g. active substance abuse) or impose a barrier to participation
- Chronic opioid use and anticoagulation therapy that cannot be stopped and could warrant a different treatment approach (e.g. phenol ablation)
- Severe motion sickness
- Seizure disorder
See the full eligibility criteria
- Patients undergoing genicular RFA will be eligible for inclusion in the study
- Patients with knee pain, baseline average of \> 4/10
- X-ray evidence of osteoarthritis of the knee
- Pain duration of \>6 weeks and no previous knee surgeries
- Patients will also only be included who have never undergone a RFA on the affected knee
- Individuals who do not have evidence of osteoarthritis on X-ray,
- Secondary gain expected to influence treatment outcomes
- Poorly controlled psychiatric condition that could affect outcome (e.g. active substance abuse) or impose a barrier to participation
- Chronic opioid use and anticoagulation therapy that cannot be stopped and could warrant a different treatment approach (e.g. phenol ablation)
- Severe motion sickness
- Seizure disorder
- Vision loss
- Pregnant
- Nursing
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.